Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -830 | -23,760 | -17,670 | -12,840 | -6,400 |
| Depreciation Amortization | 770 | 3,610 | 2,800 | 1,860 | 960 |
| Other Working Capital | -300 | -2,790 | -1,560 | -1,400 | -1,340 |
| Other Operating Activity | 310 | 2,850 | 1,910 | 1,620 | 780 |
| Operating Cash Flow | $-50 | $-20,090 | $-14,520 | $-10,760 | $-6,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -560 | -630 | -480 | -240 |
| Other Investing Activity | 0 | -1,920 | -2,350 | -1,630 | -1,630 |
| Investing Cash Flow | $-30 | $-2,480 | $-2,980 | $-2,110 | $-1,870 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -280 | 10,000 | 9,580 | 4,970 | -280 |
| Financing Cash Flow | $-280 | $10,000 | $9,580 | $4,970 | $-280 |
| Beginning Cash Position | 12,600 | 25,180 | 25,180 | 25,180 | 25,180 |
| End Cash Position | 12,230 | 12,600 | 17,260 | 17,270 | 17,020 |
| Net Cash Flow | $-370 | $-12,580 | $-7,910 | $-7,910 | $-8,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50 | -20,090 | -14,520 | -10,760 | -6,000 |
| Free Cash Flow | -50 | -20,090 | -14,520 | -10,760 | -6,000 |